Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States.
about
Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenesIn vitro activities of the Rx-01 oxazolidinones against hospital and community pathogensPhage lytic enzyme Cpl-1 as a novel antimicrobial for pneumococcal bacteremiaNew antibiotics--resistance is futileOrigin and proliferation of multiple-drug resistance in bacterial pathogensA PBP2x from a clinical isolate of Streptococcus pneumoniae exhibits an alternative mechanism for reduction of susceptibility to beta-lactam antibioticsPneumococcal capsular polysaccharide structure predicts serotype prevalenceMortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in EuropeBiological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.Insights from Streptococcus pneumoniae glucose kinase structural modelScience in the schoolhouse: an uninvited guest.New paradigms in the pathogenesis of otitis media in childrenEuropean surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach.Decreased Streptococcus pneumoniae susceptibility to oral antibiotics among children in rural Vietnam: a community studyMicroevolutionary events involving narrow host plasmids influences local fixation of vancomycin-resistance in Enterococcus populationsOfloxacin-like antibiotics inhibit pneumococcal cell wall-degrading virulence factors.Fitness costs of fluoroquinolone resistance in Streptococcus pneumoniae.Penicillin resistance and serotype distribution of Streptococcus pneumoniae in Ghanaian children less than six years of age.Molecular epidemiology of pneumococcal colonization in response to pneumococcal conjugate vaccination in children with recurrent acute otitis mediaPenicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United StatesAntibiotic use, resistance development and environmental factors: a qualitative study among healthcare professionals in Orissa, India.Genomic subtraction followed by dot blot screening of Streptococcus pneumoniae clinical and carriage isolates identifies genetic differences associated with strains that cause otitis media.Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain.What is the mechanism for persistent coexistence of drug-susceptible and drug-resistant strains of Streptococcus pneumoniae?Serotype replacement in disease after pneumococcal vaccinationPhages limit the evolution of bacterial antibiotic resistance in experimental microcosms.Treatment of community-acquired pneumonia with moxifloxacin: a meta-analysis of randomized controlled trials.Clinical practice guideline: acute otitis externa.A spatial approach for the epidemiology of antibiotic use and resistance in community-based studies: the emergence of urban clusters of Escherichia coli quinolone resistance in Sao Paulo, BrasilAntimicrobial susceptibility of invasive Streptococcus pneumoniae isolates in Portugal over an 11-year period.No coexistence for free: neutral null models for multistrain pathogens.Composite mobile genetic elements disseminating macrolide resistance in Streptococcus pneumoniae.Seasonal variation in penicillin susceptibility and invasive pneumococcal diseaseMechanisms of genome evolution of Streptococcus.Clonal success of piliated penicillin nonsusceptible pneumococci.Recent trends on the molecular biology of pneumococcal capsules, lytic enzymes, and bacteriophage.Epidemiological interpretation of antibiotic resistance studies - what are we missing?Strain characteristics of Streptococcus pneumoniae carriage and invasive disease isolates during a cluster-randomized clinical trial of the 7-valent pneumococcal conjugate vaccine.Emerging Infections Program as Surveillance for Antimicrobial Drug Resistance
P2860
Q21144638-579DA830-7606-4A3D-A15D-C4B498DD1D9AQ24600215-4FA1FC0B-17B7-4F13-98CB-CA89CDFE4998Q24656140-3A1B363B-B497-4E83-AAEF-1D0E880D416BQ24671527-00F68AF2-4DD9-42A4-AD3F-2BC04F7108E0Q24796334-E88F0439-CA93-49FA-A7D1-E4E259612A39Q27023284-9570409A-BC35-4F25-9CCB-67F102E2953DQ27642990-64EF4EFD-8D78-4635-8C18-E85DBA37AA2CQ28475595-C398E6AC-E743-4F00-9DBA-080827E6A3A5Q28477449-9E148B5F-51B7-4C83-8ADF-5C82646705FAQ30251593-02411141-D61B-4783-9F38-158E40744E65Q30375623-20C091BD-82DC-40B3-93E6-496C04D63B9DQ30434873-C93477DE-6C33-48B9-8B97-55139AC446B0Q30444709-0B5FCDBE-A452-49F8-A066-7A3676B0F7B8Q30960100-1F5EAB04-2923-4E7F-9B92-752F701FFB75Q30980181-1CC01E44-D354-41A3-9B0F-1D7D7B319E6CQ31114643-9317C193-0EA3-4923-AD6F-8BC591EC4DA3Q33212929-DEBD16DC-8E3E-4290-A2D7-149E9C28CAB2Q33264145-10BBE3CB-96F7-46CA-BB2B-F64362BCB501Q33589297-306FF399-7100-4619-B5F6-46B74057C65AQ33593187-C41CB7DF-9B2F-4011-8B8E-07F94F9E0771Q33724563-3DC9618B-6F9E-4FEF-B2D2-12A29631E3B4Q33724685-9B81103F-B495-4634-896E-59AB278C3E88Q33769043-72819700-3596-42BB-860F-5FA156792E6EQ33770121-8A39CD83-C33D-4E2F-BE3C-54DE4CB6BB37Q33856590-0ACD3A18-7E22-488C-8C28-C34B2CE5F906Q34178363-6DA00FA6-4C9E-4927-BD29-8FA062121CB7Q34426663-74489BA9-2034-4B6D-91AF-2F83FF8ADBD2Q34488843-AF846BE7-915F-41EB-8532-4F7D777245CDQ34517637-F334D324-E63B-4A75-8078-62FA20ECF876Q34668087-EF5EBF46-963C-49C3-9E6C-7447DC268E9EQ34680540-4CDE3D20-2EED-4A0D-8E87-48F41C96E9C3Q34997091-A9E473F2-A156-4A40-ADC0-095A4E2BA662Q35063708-482A815F-77CF-48AA-9411-0E41482F59B7Q35171121-8124815F-C808-43E1-A566-528020440C66Q35476337-15D7BBE1-61B9-46D8-B245-832A1941049EQ35906083-FFBF5322-7946-46B8-89A3-968EEDDE9318Q35946160-A9A8D319-DCE5-44F0-8992-9EEFE2781374Q35954276-9676E36A-9123-4520-AA74-D114ED7B3264Q35954554-A71A41C8-6A7B-4570-9EB4-1F62FF25BAE9Q35997516-E8A781E4-C124-49BE-9113-3BDEA807A76D
P2860
Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Geographic diversity and tempo ...... eumoniae in the United States.
@en
Geographic diversity and tempo ...... eumoniae in the United States.
@nl
type
label
Geographic diversity and tempo ...... eumoniae in the United States.
@en
Geographic diversity and tempo ...... eumoniae in the United States.
@nl
prefLabel
Geographic diversity and tempo ...... eumoniae in the United States.
@en
Geographic diversity and tempo ...... eumoniae in the United States.
@nl
P2093
P50
P356
P1433
P1476
Geographic diversity and tempo ...... eumoniae in the United States.
@en
P2093
Althea W McCormick
Arthur Reingold
Cynthia G Whitney
James Hadler
Lee H Harrison
Matthew H Samore
Monica M Farley
Nancy M Bennett
Paul Cieslak
P2888
P304
P356
10.1038/NM839
P407
P577
2003-03-10T00:00:00Z